Modern Healthcare Relies Heavily on the Microbiome Because of its Multiple Functions
Despite having nearly identical
genetics, there is a huge diversity of phenotypes among humans due to the
minute variations in our DNA. In contrast, the human microbiome's
metagenome—the total amount of DNA found in the microbes that live inside our
bodies is much more variable, with the majority of healthy people only sharing
a third of its constituent genes. Thus, since at least the 1960s through the
Human Microbiome Project and beyond, comprehending this variability in the
"healthy microbiome" has been a significant challenge in microbiome
research.
The Global
Human Microbiome Market is estimated to be valued at US$ 91,075.4 Mn in 2021 and is expected to exhibit a CAGR of 18.9% over the forecast period
(2021-2028).
A single microbe, such as a
bacteria, fungus, or virus, was identified, isolated, and cultured in the past
for the purpose of studying human
microbiome. These pathogen-fighting therapies and medications were
developed by scientists using the organisms they collected from patients with
acute or chronic infections. Although treating human illness with this strategy
has been incredibly effective, it's important to remember that this strategy
has also produced bacteria that are resistant to antibiotics. Recent
investigations into the human microbiota offer great hope for a novel strategy
to improve human health and wellbeing.
The ranges and diversity of both
taxonomic compositions and functional potentials typically observed in the
microbiomes of healthy populations, as well as potential driving factors like
geography, diet, and lifestyle, have been documented in a number of
population-scale studies toward this goal. In this article, we examine various
definitions of a "healthy microbiome," the ranges of a healthy
microbial diversity, and unresolved issues that need to be addressed in the
future, such as the characterization of molecular function and the development
of ecological therapies.
Comments
Post a Comment